fda bpc-157 compounding safety concerns Targets GLP-1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling Understanding the Legal Risks of
Description
If we are treating autoimmunity or pernicious anemia, you will receive B12 weekly or twice weekly for 6-12 weeks
If you're over 50, your risk increases significantly as stomach acid production naturally declines
Published analyses report contamination prevalence from 10% to 35% in some supplement categories
doi: 10.1007/s00535-016-1182-4
A named supplier is part of the quality signal
